APPLICATIONS
- Detection of patients at risk for arterial hypertension (AHT) and cardiovascular complications
- Early care therapeutic strategy to prevent progression of chronic inflammation towards cardiovascular complications
- Companion diagnostic for developing targeted pharmacological treatment for secondary AHT
DESCRIPTION
- Identification of 2 circulating inflammatory metabolites triggering AHT
- High expression of these metabolites in individuals with active clinical and immunological states
- Metabolites able to induce the main clinical features of AHT in mice
- On-going biomedical study for monitoring the metabolites in patients with hypertension
BENEFITS
- Better management for patients subject to chronic inflammation
- Prevention of cardiovascular complications associated with hypertension
Opportunity to develop a specific treatment against essential hypertension
IP
This technology is protected by a patent application